YY1 and hepatocellular carcinoma: Extending these observations to HCC, we profiled YY1 in the same 37 patients (clinical characteristics in Table S1) treated with anti‐PD‐1 blockade and confirmed that high YY1 expression independently predicted markedly shortened PFS (Figure 1D).